All Stories

  1. Surgical and nutritional outcomes of laparoscopic proximal gastrectomy versus total gastrectomy: a meta-analysis
  2. Is laparoscopic gastrectomy an oncologically safe procedure in serosa-positive (pT4a) gastric cancer patients?
  3. Feasibility of laparoscopic gastrectomy for patients with poor physical status: a retrospective cohort study based on a nationwide registry database in Japan
  4. IGFBP1 Is a Predictive Factor for Haematogenous Metastasis in Patients With Gastric Cancer
  5. Intraoperative Body Fluid Amylase as a Novel Indicator of Postgastrectomy Pancreatic Fistula
  6. A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
  7. Feasibility of laparoscopic total gastrectomy in overweight patients: Implications of less impact of overweight on laparoscopic versus open approach
  8. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression
  9. Long-term functional outcomes of Roux-en-Y versus Billroth I reconstructions after laparoscopic distal gastrectomy for gastric cancer: a propensity-score matching analysis
  10. Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer
  11. Intraoperative pancreatic injury gives rise to severe postoperative pancreatic fistula: results of a review of unedited videos of the laparoscopic surgical procedures
  12. Feasibility of a Clinical Pathway With Early Oral Intake and Discharge for Laparoscopic Gastrectomy
  13. Cadherin 5 Ιs a Significant Risk Factor for Hematogenous Recurrence and a Prognostic Factor in Locally Advanced Gastric Cancer
  14. Intracorporeal esophagojejunostomy with Roux-en-Y reconstruction after laparoscopic total gastrectomy
  15. Laparoscopic Distal Gastrectomy is Feasible in Very Elderly Patients as Compared with Open Distal Gastrectomy
  16. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis
  17. High expression of P21‑activated kinase 5 protein is associated with poor survival in gastric cancer
  18. High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
  19. Esophagojejunostomy Using the Purse-String Suturing Device After Laparoscopic Total or Proximal Gastrectomy for Gastric Cancer
  20. Double-tract reconstruction after laparoscopic proximal gastrectomy using detachable ENDO-PSD
  21. TPX2 expression is associated with poor survival in gastric cancer
  22. Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
  23. Risk Factor of Pancreatic Fistula after Radical Gastrectomy from the Viewpoint of Fatty Pancreas
  24. Commentary on a randomized controlled trial of vagus nerve-preserving distal gastrectomy in early gastric cancer
  25. Cadherin 5 expression correlates with poor survival in human gastric cancer
  26. Feasibility of laparoscopy-assisted gastrectomy for patients with poor physical status: A propensity-score matching study
  27. Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies
  28. Prognostic significance of PAK4 expression in gastric cancer
  29. Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer
  30. Clinical significance of platelet derived growth factor-C and -D in gastric cancer
  31. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer
  32. Laparoscopic distal gastrectomy reduced surgical site infection as compared with open distal gastrectomy for gastric cancer in a meta-analysis of both randomized controlled and case-controlled studies
  33. Clinical significance of MET in gastric cancer
  34. Systematic review of anastomotic complications of esophagojejunostomy after laparoscopic total gastrectomy
  35. Long-term outcomes of laparoscopic gastrectomy for gastric cancer
  36. Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
  37. Assessment of Serum Copper State after Gastrectomy with Roux-en-Y Reconstruction for Gastric Cancer
  38. Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer
  39. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer
  40. Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: Reliable results following long-term follow-up
  41. Risk Factors for Post-Operative Pulmonary Complications after Gastrectomy for Gastric Cancer
  42. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer
  43. Critical analysis of the potential for therapeutic targeting of mammalian target of rapamycin (mTOR) in gastric cancer
  44. Laparoscopy Versus Open Distal Gastrectomy for Advanced Gastric Cancer
  45. Long-Term Effectiveness of Preserved Celiac Branch of Vagal Nerve After Roux-en-Y Reconstruction in Laparoscopy-Assisted Distal Gastrectomy
  46. Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
  47. β-Shaped intracorporeal Roux-en-Y reconstruction after totally laparoscopic distal gastrectomy
  48. CD49fhigh Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors
  49. EphA4 is a prognostic factor in gastric cancer
  50. Petersen’s hernia after laparoscopic distal gastrectomy with Roux-en-Y reconstruction for gastric cancer
  51. Clinical Outcomes of Laparoscopy-assisted Gastrectomy for Patients With Heart Disease
  52. Feasibility of laparoscopy-assisted gastrectomy for patients with chronic obstructive pulmonary disease
  53. A Case of AFP-Producing, True Gastric Carcinosarcoma
  54. Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer
  55. Prognoses of GEP-Nets with Undetermined Malignant Potentials of their Primary Sites
  56. The Importance of Clinical Information in Patients with Gastroenteropancreatic Neuroendocrine Tumor
  57. Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy
  58. Prognostic value of RKIP and p-ERK in gastric cancer
  59. A case of granulocyte-colony stimulating factor producing gastric cancer in a young adult
  60. Vimentin expression is associated with decreased survival in gastric cancer
  61. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer
  62. Efficacy of celiac branch preservation in Roux-en-y reconstruction after laparoscopy-assisted distal gastrectomy
  63. Prognostic value of co-expression of STAT3, mTOR and EGFR in gastric cancer
  64. Scoring System for Evaluating Functional Disorders Following Laparoscopy-Assisted Distal Gastrectomy
  65. Laparoscopy-Assisted Gastrectomy in Patients Older Than 80
  66. Laparoscopic Internal Hernia Reposition after Laparoscopy-assisted Distal Gastrectomy with Roux-en-Y Reconstruction
  67. A Case of Multiple Primary Cancers that underwent a Radical Resection of both Remnant Gastric Cancer and Hepatocelluar Carcinoma, after an Esopahagectomy with Reconstruction Using the Colon
  68. Relation between outcomes and localisation of p-mTOR expression in gastric cancer
  69. High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer
  70. Functional evaluation after vagus nerve–sparing laparoscopically assisted distal gastrectomy
  71. A Comparison of Roux-en-Y and Billroth-I Reconstruction After Laparoscopy-assisted Distal Gastrectomy
  72. Preliminary Experience Using a Computer-mediated Flexible Circular Stapler in Laparoscopic Esophagogastrostomy
  73. CURRENT STATUS AND EVALUATION OF LAPAROSCOPIC SURGERY FOR GASTRIC CANCER
  74. Effect of Obesity on Technical Feasibility and Postoperative Outcomes of Laparoscopy-Assisted Distal Gastrectomy—Comparison with Open Distal Gastrectomy
  75. MethylatedTMS1 andDAPK genes predict prognosis and response to chemotherapy in gastric cancer
  76. P46 Short segment Barrett??s esophagus defined by lower esophageal palisade vessels
  77. Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer
  78. 進行・再発食道癌に対するsecond‐lineとしてのDocetaxel+Nedaplatin併用療法の検討
  79. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis
  80. Technique of Vagus-Nerve Sparing Laparoscopy-Assisted Distal Gastrectomy
  81. ONE-HUNDRED AND NINE CASES OF TENSION-FREE HERNIA REPAIR FOR ADULT INGUINAL AND FEMORAL HERNIA
  82. A Case of Huge Colonic Adenoma with Juvenile Component in a Child